Metastatic Prostate Cancer: Treatment Options

Vérane Achard1,2, Paul Martin Putora3,4, Aurelius Omlin5

  • 1Department of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland.

Oncology
|November 15, 2021
PubMed
Summary

New treatments significantly improve survival for metastatic prostate cancer (PCa). Combining therapies upfront or sequencing them effectively is crucial for optimizing outcomes in hormone-sensitive and castration-resistant PCa.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K